m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner

[1]  Quanbo Zhou,et al.  circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway , 2022, Journal of experimental & clinical cancer research : CR.

[2]  Janel L. Kopp,et al.  Cell Type of Pancreatic Ductal Adenocarcinoma Origin: Implications for Prognosis and Clinical Outcomes , 2021, Visceral Medicine.

[3]  L. de Geus-Oei,et al.  Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma , 2021, Cancers.

[4]  Rahul Peravali,et al.  The Relationship between Acute and Chronic Pancreatitis with Pancreatic Adenocarcinoma: Review , 2021, Diseases.

[5]  W. El-Deiry,et al.  Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma , 2021, Frontiers in Pharmacology.

[6]  Zhi-wen Zhang,et al.  RNA m6A Demethylase ALKBH5 Protects Against Pancreatic Ductal Adenocarcinoma via Targeting Regulators of Iron Metabolism , 2021, Frontiers in Cell and Developmental Biology.

[7]  Xiao‐Yu Yin,et al.  HNRNPC impedes m6A-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinoma. , 2021, Cancer letters.

[8]  C. Hwang,et al.  Epigenetic Alterations in Pancreatic Cancer Metastasis , 2021, Biomolecules.

[9]  Prosenjit Paul,et al.  Circular RNAs in cancer and diabetes , 2021, Journal of Genetics.

[10]  O. Thorlacius-Ussing,et al.  Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature Update , 2021, Epigenomes.

[11]  W. Yuan,et al.  N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization , 2021, Theranostics.

[12]  G. Shan,et al.  CircRNA in cancer: Fundamental mechanism and clinical potential. , 2021, Cancer letters.

[13]  Wenxin Qin,et al.  circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity , 2021, Nature communications.

[14]  Kefei Yuan,et al.  Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR , 2020, Theranostics.

[15]  Chaofeng Hou,et al.  The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs , 2020, Molecular Cancer.

[16]  Xuan Du,et al.  Identification and characterization of tumorigenic circular RNAs in cervical cancer. , 2020, Cellular signalling.

[17]  S. Banerjee,et al.  Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

[18]  Jie-Wei Chen,et al.  N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis , 2019, Nature Communications.

[19]  Tianxin Lin,et al.  Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis , 2019, Molecular Cancer.

[20]  Yi Xing,et al.  Genome-Wide Maps of m6A circRNAs Identify Widespread and Cell-Type-Specific Methylation Patterns that Are Distinct from mRNAs. , 2017, Cell reports.

[21]  Feng Liu,et al.  METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6‐methyladenosine‐dependent primary MicroRNA processing , 2017, Hepatology.

[22]  S. Hüttelmaier,et al.  Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains , 2013, Biological chemistry.

[23]  M. Lederer,et al.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? , 2012, Cellular and Molecular Life Sciences.